125 related articles for article (PubMed ID: 21703036)
1. Name that prostate cancer drug.
Gomella LG
Can J Urol; 2011 Jun; 18(3):5666. PubMed ID: 21703036
[No Abstract] [Full Text] [Related]
2. A renaissance in the medical treatment of advanced prostate cancer.
Rove KO; Flaig TW
Oncology (Williston Park); 2010 Dec; 24(14):1308-13, 1318. PubMed ID: 21294475
[TBL] [Abstract][Full Text] [Related]
3. US Food and Drug Administration approval of drugs for the treatment of prostate cancer: a new era has begun.
D'Amico AV
J Clin Oncol; 2014 Feb; 32(4):362-4. PubMed ID: 24344221
[No Abstract] [Full Text] [Related]
4. [New hope in the treatment of advanced cancer of the prostate in 2012].
Massard C
Bull Cancer; 2012 Jul; 99 Suppl 1():S3. PubMed ID: 23767051
[No Abstract] [Full Text] [Related]
5. [Strategy in advanced castration-resistant prostate cancer].
Gross-Goupil M; Roca S; Pasticier G; Ravaud A
Bull Cancer; 2012 Jul; 99 Suppl 1():S37-45. PubMed ID: 22522582
[TBL] [Abstract][Full Text] [Related]
6. Contemporary management of metastatic castration-resistant prostate cancer.
Sonpavde G; Sternberg CN
Curr Opin Urol; 2011 May; 21(3):241-7. PubMed ID: 21455038
[TBL] [Abstract][Full Text] [Related]
7. Optimal management of bone metastases in prostate cancer.
Aljumaily R; Mathew P
Curr Oncol Rep; 2011 Jun; 13(3):222-30. PubMed ID: 21336561
[TBL] [Abstract][Full Text] [Related]
8. [Comment to the status article about denosumab].
Brasso K; Iversen P
Ugeskr Laeger; 2011 Feb; 173(9):677; author reply 677. PubMed ID: 21473172
[No Abstract] [Full Text] [Related]
9. Care of the elderly patient with prostate cancer: what's new and what's the same.
Johnson TM
Consult Pharm; 2011 Jun; 26(6):390-9. PubMed ID: 21628138
[TBL] [Abstract][Full Text] [Related]
10. New prostate cancer drugs hold promise.
Cancer; 2013 Jan; 119(2):247-8. PubMed ID: 23292897
[No Abstract] [Full Text] [Related]
11. Safety and efficacy of denosumab in giant-cell tumour of bone.
Kyrgidis A; Toulis K
Lancet Oncol; 2010 Jun; 11(6):513-4. PubMed ID: 20522379
[No Abstract] [Full Text] [Related]
12. A new era for castrate resistant prostate cancer: a treatment review and update.
Fong MK; Hare R; Jarkowski A
J Oncol Pharm Pract; 2012 Sep; 18(3):343-54. PubMed ID: 22343966
[TBL] [Abstract][Full Text] [Related]
13. Denosumab: a breakthrough in treatment of giant-cell tumour of bone?
Balke M; Hardes J
Lancet Oncol; 2010 Mar; 11(3):218-9. PubMed ID: 20149737
[No Abstract] [Full Text] [Related]
14. Castration-refractory prostate cancer: new therapies, new questions.
Appleman LJ
Oncology (Williston Park); 2010 Dec; 24(14):1318-9, 1326. PubMed ID: 21294476
[No Abstract] [Full Text] [Related]
15. Role of denosumab in prostate cancer.
Helo S; Manger JP; Krupski TL
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):231-6. PubMed ID: 22370723
[TBL] [Abstract][Full Text] [Related]
16. Speeding dating for docetaxel and recent debutantes in castration-resistant prostate cancer: 'plus or minus' may be a minus.
Dorff TB; Quinn DI
Ann Oncol; 2013 Feb; 24(2):270-272. PubMed ID: 23341479
[No Abstract] [Full Text] [Related]
17. New treatment options for patients with metastatic castration-resistant prostate cancer.
Higano CS
Cancer Treat Rev; 2012 Aug; 38(5):340-5. PubMed ID: 21944872
[TBL] [Abstract][Full Text] [Related]
18. Clinical development of novel therapeutics for castration-resistant prostate cancer: historic challenges and recent successes.
Galsky MD; Small AC; Tsao CK; Oh WK
CA Cancer J Clin; 2012; 62(5):299-308. PubMed ID: 22535487
[TBL] [Abstract][Full Text] [Related]
19. Highlights from the 2005 American Society of Clinical Oncology Prostate Cancer Symposium, Orlando, Florida.
Reddy GK; Gibson TB; Hutson T; Marianni S; Sartor O
Clin Prostate Cancer; 2005 Mar; 3(4):206-10. PubMed ID: 15882475
[No Abstract] [Full Text] [Related]
20. Trials define anti-tumor effects of anti-resorptive agents: denosumab ahead of zoledronate 2 to 1.
Weintraub B
BioDrugs; 2011 Apr; 25(2):135-8. PubMed ID: 21443276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
